Microdosing Semaglutide for Weight Maintenance: Who It's For

You have reached your goal weight. The active weight loss phase is done, and now you are thinking about what comes next. If you have been on semaglutide, you have probably wondered: can you stay on it at a lower dose, or do you need to stop completely?

The answer is more nuanced than yes or no. Semaglutide microdosing, or staying on a significantly lower maintenance dose, is a clinical strategy that some providers use for patients who want to maintain their results. It is not an official FDA-approved indication, and there is no standardized protocol. But it is a real option worth discussing with your provider if you are interested in continuing medication at a lower cost and lower dose.

What “semaglutide microdosing” actually means

Semaglutide microdosing does not have a formal definition in medical literature. When providers and patients talk about it, they mean staying on semaglutide at doses substantially lower than the ones used for active weight loss.

Active weight loss typically requires doses of 1.0mg to 2.4mg per week. Maintenance microdoses are often much lower: 0.25mg or 0.5mg per week. The exact dose depends on your individual response, your prior treatment history, and how much appetite control you need to maintain your current weight.

The key point: your provider is making this dosing decision based on clinical judgment, not from a textbook protocol. It is personalized to your situation.

Why lower doses might work for maintenance

Semaglutide is a GLP-1 receptor agonist that amplifies the natural satiety signal your body produces after meals. The science shows that appetite suppression occurs across the full dose range, not just at the highest therapeutic levels.

Think of appetite signaling like a volume knob. At full volume (1.0mg to 2.4mg per week), the appetite signal is turned way down, which supports active weight loss. At half-volume or less (0.25mg to 0.5mg per week), the signal is turned down enough to reduce the constant urge to eat, but not so aggressively that you feel completely suppressed.

For someone who has already lost weight and built new eating habits, that lower-volume appetite reduction may be enough to maintain stability without the side effects or cost of a full weight-loss dose.

What the STEP 4 trial showed

The strongest evidence for why some people consider maintenance dosing comes from the STEP trial data. The STEP 4 trial, published in JAMA in 2021^[1], compared what happened to people who stopped semaglutide versus those who continued it at maintenance doses.

The findings were striking: patients who stopped semaglutide completely regained approximately two-thirds of the body weight they had lost over the following year. Patients who continued on maintenance doses maintained their results.

This tells you something important about what semaglutide does. It is not just jumpstarting weight loss; it is actively managing appetite signals. When you stop the medication, that appetite regulation goes away, and for many people, the urge to eat returns to pre-treatment levels. The regain is not a sign of failure. It is a sign that the medication was doing a real job managing a biological process.

Why maintenance is different from stopping entirely

If you stop semaglutide completely, you are left with your baseline appetite signals. For many people who started on GLP-1 or semaglutide in the first place, those baseline signals are difficult to manage. The STEP 4 data shows that directly: significant weight regain within a year is common.

With a maintenance microdose, you are not eliminating appetite regulation; you are keeping it at a lower level. It is less aggressive than the active weight-loss dose, but it is still present.

The biology does not change when you go from 2.4mg to 0.5mg. The GLP-1 receptors are still getting activated, still reducing appetite, still slowing gastric emptying. You are just using a lower dose to achieve a less aggressive effect.

What microdosing looks like in practice

If your provider recommends a maintenance microdose, here is what that might look like:

You were on 2.4mg per week for active weight loss. Your provider discusses stepping down to 0.5mg per week for maintenance. You do this gradually, over a few weeks, monitoring how you feel and how your weight behaves.

At 0.5mg per week, you might find that your appetite is reduced but not suppressed. You feel normal hunger at meals, but you do not feel compelled to snack or think about food constantly throughout the day. Your weight stays stable.

The dose is adjusted based on your individual response. If 0.5mg is too much and you are losing weight when you want to maintain, you might go down to 0.25mg. If 0.5mg is not enough and you are starting to experience hunger creep, your provider might suggest stepping up or considering a different approach.

This is clinical judgment, not protocol. Your provider is making decisions based on your specific situation: your response to medication, your eating habits, your goals, and your health history.

Semaglutide vs. tirzepatide for maintenance

Both medications are used in microdose maintenance contexts, but they work differently and are not interchangeable.

Semaglutide is a GLP-1 receptor agonist with a well-characterized dose-response curve. It has been in clinical use longer than tirzepatide, so there is more real-world data on how different doses perform. Some patients maintain comfortably on a fraction of their active treatment dose.

Tirzepatide is a dual GLP-1 and GIP receptor agonist. The additional GIP receptor activation gives it slightly different potency. Some patients transition to tirzepatide for maintenance if they had a strong response during active treatment, while others prefer to stay with semaglutide if they are doing well.

Your provider will help you decide what makes sense. If you used semaglutide during active treatment, you typically continue with semaglutide for maintenance, unless there is a clinical reason to switch. Read more: Microdosing Tirzepatide.

The role of compounded semaglutide in maintenance

The Transformation Health Microdose program uses compounded semaglutide prepared by US-based, state-licensed compounding pharmacies. Compounded medications are not FDA-approved and differ from branded versions, but they allow providers to customize doses for individual maintenance needs.

At microdose levels (0.25mg to 0.5mg weekly), the cost difference between branded and compounded options becomes significant. Branded options at maintenance doses are often not commercially available in packaging designed for long-term use. Compounded formulations allow your provider to specify the exact dose you need, reducing waste and cost.

The Transformation Health Microdose program

Transformation Health offers a Microdose program specifically for people at goal weight who want to stay on a maintenance dose. Here is what qualifies and what is included.

Who qualifies:

• Prior GLP-1 experience (you have completed at least one full cycle of weight loss medication)
• Current BMI of 20 or higher
• No contraindications to continued semaglutide use (your provider will assess this)

What is included ($199 per month):

• Your compounded semaglutide medication at your prescribed maintenance dose
• Provider check-ins to monitor your progress and adjust your dose as needed
• Lab work to ensure your health markers remain stable
• Medical weight loss coaching to support habit maintenance
• No hidden fees. No surprises at billing time.

The program is designed for people who have done the hard work of losing weight and want clinical support for the maintenance phase. It costs less than the standard semaglutide program ($249 per month) because you are on a lower dose, but you still get the same level of provider oversight and support.

How to get evaluated

If you are interested in whether semaglutide microdosing is right for you, here is the process:

1. Complete a free online assessment. You will answer questions about your health history, your prior experience with GLP-1 medications, your current weight, and your goals.
2. An independent, licensed provider reviews your assessment. They look at your history, your current health, and whether a maintenance dose is medically appropriate for your situation.
3. If your provider determines that you are a good candidate, you will have a consultation (by phone or video, depending on your state) to discuss your specific maintenance plan.
4. If you proceed, your medication is prepared by a licensed US compounding pharmacy and shipped to your door.
5. You start on your prescribed maintenance dose. Your provider checks in regularly to monitor your progress and adjust your dose if needed.

Residents of AR, DC, DE, MS, NM, RI, and WV are required by state law to complete a live video consultation before a prescription can be issued.

What happens if maintenance is not right for you

Microdosing is not the only path after reaching goal weight. Some people do better stopping medication entirely and maintaining through diet and exercise alone. Some people find that even a microdose is too much or not necessary. Some people stay on their active-weight-loss dose if they continue to have strong appetite signals.

Your provider will discuss what makes sense for your specific situation. The Microdose program is one option among several. The goal is to find what works for you long-term, not to push you into any particular approach.

Key takeaways

• Semaglutide microdosing is not an FDA-approved indication, but it is a clinical strategy some providers use for maintenance after active weight loss.
• There is no official protocol. Your provider determines the right maintenance dose for your situation based on your response, goals, and health history.
• The STEP 4 trial showed that stopping semaglutide entirely leads to significant weight regain for many people (approximately two-thirds of lost weight over a year), while staying on a maintenance dose maintains results.
• Maintenance doses are typically 0.25mg to 0.5mg per week, well below the 1.0mg to 2.4mg used for active weight loss.
• The Transformation Health Microdose program is $199 per month, all-inclusive, and is designed for people at goal weight with prior GLP-1 experience.
• Your provider makes the decision about whether maintenance dosing is appropriate for you based on your individual health history and goals.

What to read next

Learn more about the full path after reaching goal weight by reading GLP-1 Microdosing and Maintenance. If you are thinking about stopping medication entirely, Stopping Weight Loss Medication: What Happens walks through the trial data and what to expect.

For more details on how compounded semaglutide works and what it includes at our standard dose, see Compounded Semaglutide: What It Is and How It Works.

Citations

[1] Rubino DM, et al. “Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults.” JAMA 2021;325(14):1414-1425. https://pubmed.ncbi.nlm.nih.gov/33755728/